Health
Recurrent GBM brain tumors with few mutations respond best to immunotherapy – Duke Department of Neurology
Glioblastoma brain tumors are especially perplexing.
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after theyve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Dukes Preston Robert Tisch Brain Tumor Center, including the Neurology Department’s Katherine Peters, MD, PhD, Dina Randazzo,…
-
General14 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News13 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
Noosa News14 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
Noosa News18 hours agoMary River cod thriving in Brisbane River catchment, century after relative went extinct